Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K D Tew

Showing results (11-20 of 147) with videos related to

Pageof 15
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1980
Cyclophosphamide and cis-dichlorodiammine platinum (11). Nonempiric scheduling to spare dose-limiting tissues in the ratK D Tew, D M Taylor
Cancer Research|September 1, 1986
Differences in the nuclear matrix phosphoproteins of a wild-type and nitrogen mustard-resistant rat breast carcinoma cell lineB C Moy, K D Tew
European Journal of Cancer|February 1, 1978
The relationship of thymidine metabolism to the use of fractional incorporation as a measure of DNA synthesis and tissue proliferationK D Tew, D M Taylor
Cancer Research|August 1, 1985
Antimicrotubule effects of estramustine, an antiprostatic tumor drugM E Stearns, K D Tew
Journal of Cell Science|March 1, 1988
Estramustine binds MAP-2 to inhibit microtubule assembly in vitroM E Stearns, K D Tew
Biochemical Pharmacology|June 15, 1989
Identification of a glutathione S-transferase associated with microsomes of tumor cells resistant to nitrogen mustardsM L Clapper, K D Tew
Journal of the National Cancer Institute|May 1, 1977
Studies with cyclophosphamide labeled with phosphorus-32: nucleic acid alkylation and its effect on DNA synthesis in rat tumor and normal tissuesK D Tew, D M Taylor
Urological Research|January 1, 1987
Hormone-independent, non-alkylating mechanism of cytotoxicity for estramustineK D Tew, M E Stearns
Chemico-Biological Interactions|July 1, 1985
Poly(adenosine diphosphate-ribosylation) of nuclear matrix proteins in alkylating agent resistant and sensitive cell linesB C Moy, K D Tew
Cancer Surveys|January 1, 1991
Mechanism based chemotherapy for prostate cancerV R Sheridan, K D Tew
Pageof 15

Showing results (11-20 of 147) with videos related to

Sort By:
Pageof 15
Cancer Chemotherapy and Pharmacology|January 1, 1980
Cyclophosphamide and cis-dichlorodiammine platinum (11). Nonempiric scheduling to spare dose-limiting tissues in the ratK D Tew, D M Taylor
Cancer Research|September 1, 1986
Differences in the nuclear matrix phosphoproteins of a wild-type and nitrogen mustard-resistant rat breast carcinoma cell lineB C Moy, K D Tew
European Journal of Cancer|February 1, 1978
The relationship of thymidine metabolism to the use of fractional incorporation as a measure of DNA synthesis and tissue proliferationK D Tew, D M Taylor
Cancer Research|August 1, 1985
Antimicrotubule effects of estramustine, an antiprostatic tumor drugM E Stearns, K D Tew
Journal of Cell Science|March 1, 1988
Estramustine binds MAP-2 to inhibit microtubule assembly in vitroM E Stearns, K D Tew
Biochemical Pharmacology|June 15, 1989
Identification of a glutathione S-transferase associated with microsomes of tumor cells resistant to nitrogen mustardsM L Clapper, K D Tew
Journal of the National Cancer Institute|May 1, 1977
Studies with cyclophosphamide labeled with phosphorus-32: nucleic acid alkylation and its effect on DNA synthesis in rat tumor and normal tissuesK D Tew, D M Taylor
Urological Research|January 1, 1987
Hormone-independent, non-alkylating mechanism of cytotoxicity for estramustineK D Tew, M E Stearns
Chemico-Biological Interactions|July 1, 1985
Poly(adenosine diphosphate-ribosylation) of nuclear matrix proteins in alkylating agent resistant and sensitive cell linesB C Moy, K D Tew
Cancer Surveys|January 1, 1991
Mechanism based chemotherapy for prostate cancerV R Sheridan, K D Tew
Pageof 15